Macular Edema following cataract surgery in Diabetic type 2 patients

Macular Edema following cataract surgery in Diabetic type 2 patients - DME & Cataract

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33232

Enrollment

170

Registered

2009-09-10

Start date

2010-02-02

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic macular edema

Interventions

Group 1: No intervention

Group 2: Phaco-emulsification, Dexamethason collyre 3/d.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Informed consent - Cataract - Diabetes Mellitus type 2 - Mild to moderate non-proliferative diabetic retinopathy

Exclusion criteria

Exclusion criteria: - Severity of cataract obstructing ophthalmic inspection (i.e. NO5, NC5, NO6, NC6, C5, P5) and/or (sufficiently accurate) OCT measurements (i.e. a Signal Strength Index

Design outcomes

Primary

Measure	Time frame
Incidence DME, BCVA, foveal thickness.	—

Secondary

Measure	Time frame
IOP.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)